Integer Holdings Co. (NYSE:ITGR) Receives $146.56 Consensus PT from Brokerages

Integer Holdings Co. (NYSE:ITGR) has been assigned a consensus recommendation of “Moderate Buy” from the nine ratings firms that are presently covering the company, Marketbeat.com reports. One research analyst has rated the stock with a hold rating and eight have assigned a buy rating to the company. The average twelve-month target price among analysts that have covered the stock in the last year is $146.56.

A number of research firms have issued reports on ITGR. Piper Sandler reaffirmed an “overweight” rating and issued a $140.00 price target (up previously from $125.00) on shares of Integer in a research report on Friday, October 25th. Citigroup lifted their price target on Integer from $130.00 to $145.00 and gave the stock a “neutral” rating in a research report on Wednesday, December 11th. KeyCorp lifted their target price on Integer from $144.00 to $154.00 and gave the company an “overweight” rating in a research note on Friday, January 24th. Truist Financial lifted their price target on Integer from $147.00 to $163.00 and gave the company a “buy” rating in a research note on Wednesday, December 11th. Finally, Wells Fargo & Company restated an “overweight” rating and issued a $160.00 price target on shares of Integer in a research note on Tuesday, December 3rd.

Hedge Funds Weigh In On Integer

Several institutional investors have recently added to or reduced their stakes in ITGR. Loomis Sayles & Co. L P grew its position in Integer by 3.0% during the third quarter. Loomis Sayles & Co. L P now owns 538,027 shares of the medical equipment provider’s stock valued at $69,943,000 after acquiring an additional 15,446 shares during the period. Jane Street Group LLC raised its stake in Integer by 23.3% during the third quarter. Jane Street Group LLC now owns 151,397 shares of the medical equipment provider’s stock valued at $19,682,000 after buying an additional 28,572 shares in the last quarter. Verition Fund Management LLC raised its position in shares of Integer by 17.4% during the 3rd quarter. Verition Fund Management LLC now owns 3,470 shares of the medical equipment provider’s stock worth $451,000 after purchasing an additional 515 shares during the period. Versant Capital Management Inc raised its position in shares of Integer by 98.4% during the 4th quarter. Versant Capital Management Inc now owns 369 shares of the medical equipment provider’s stock worth $49,000 after purchasing an additional 183 shares during the period. Finally, Lord Abbett & CO. LLC raised its position in shares of Integer by 3.5% during the 3rd quarter. Lord Abbett & CO. LLC now owns 290,120 shares of the medical equipment provider’s stock worth $37,716,000 after purchasing an additional 9,754 shares during the period. 99.29% of the stock is currently owned by institutional investors and hedge funds.

Integer Stock Performance

Shares of Integer stock opened at $143.40 on Friday. The business has a 50-day moving average of $137.92 and a 200 day moving average of $132.20. Integer has a 12 month low of $97.49 and a 12 month high of $146.36. The stock has a market capitalization of $4.81 billion, a price-to-earnings ratio of 44.26, a price-to-earnings-growth ratio of 1.80 and a beta of 1.13. The company has a debt-to-equity ratio of 0.67, a current ratio of 3.28 and a quick ratio of 2.09.

About Integer

Integer Holdings Corporation operates as a medical device outsource manufacturer in the United States, Puerto Rico, Costa Rica, and internationally. It operates through two segments, Medical and Non-Medical. The company offers products for interventional cardiology, structural heart, heart failure, peripheral vascular, neurovascular, interventional oncology, electrophysiology, vascular access, infusion therapy, hemodialysis, non-vascular, urology, and gastroenterology procedures.